TRULIEVE CANNABIS CORP. Accretion Expense
TRULIEVE CANNABIS CORP. (TRLV) reported Accretion Expense of $5.30 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AccretionExpense · last filed 2024-02-29
- TRULIEVE CANNABIS CORP. accretion expense for the quarter ending 2023-12-31 was $1.00M, a 28.57% decline year-over-year.
- TRULIEVE CANNABIS CORP. accretion expense for the quarter ending 2023-09-30 was $1.50M, a 15.38% increase year-over-year.
- TRULIEVE CANNABIS CORP. accretion expense for the quarter ending 2023-06-30 was $1.40M, a 7.69% increase year-over-year.
- TRULIEVE CANNABIS CORP. accretion expense for the quarter ending 2023-03-31 was $1.40M, a 16.67% increase year-over-year.
- TRULIEVE CANNABIS CORP. accretion expense for fiscal 2023 was $5.30M, a 1.92% increase from fiscal 2022.
- TRULIEVE CANNABIS CORP. accretion expense for fiscal 2022 was $5.20M, a 48.57% increase from fiscal 2021.
- TRULIEVE CANNABIS CORP. accretion expense for fiscal 2021 was $3.50M, a 25.00% increase from fiscal 2020.
- TRULIEVE CANNABIS CORP. accretion expense for fiscal 2020 was $2.80M.
| Period end | Accretion Expense 3 month | Accretion Expense 6 month | Accretion Expense 9 month | Accretion Expense 12 month |
|---|---|---|---|---|
| 2023-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $2.50M derived: sum of 2 quarters · filed 2024-02-29 | $3.90M derived: sum of 3 quarters · filed 2024-02-29 | $5.30M 10-K · filed 2024-02-29 |
| 2023-09-30 | $1.50M 10-Q · filed 2023-11-09 | $2.90M derived: sum of 2 quarters · filed 2023-11-09 | $4.30M 10-Q · filed 2023-11-09 | $5.70M derived: sum of 4 quarters · filed 2024-02-29 |
| 2023-06-30 | $1.40M 10-Q · filed 2023-08-09 | $2.80M 10-Q · filed 2023-08-09 | $4.20M derived: sum of 3 quarters · filed 2024-02-29 | $5.50M derived: sum of 4 quarters · filed 2024-02-29 |
| 2023-03-31 | $1.40M 10-Q · filed 2023-05-10 | $2.80M derived: sum of 2 quarters · filed 2024-02-29 | $4.10M derived: sum of 3 quarters · filed 2024-02-29 | $5.40M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $2.70M derived: sum of 2 quarters · filed 2024-02-29 | $4.00M derived: sum of 3 quarters · filed 2024-02-29 | $5.20M 10-K · filed 2024-02-29 |
| 2022-09-30 | $1.30M 10-Q · filed 2023-11-09 | $2.60M derived: sum of 2 quarters · filed 2023-11-09 | $3.80M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $1.30M 10-Q · filed 2023-08-09 | $2.50M 10-Q · filed 2023-08-09 | ||
| 2022-03-31 | $1.20M 10-Q · filed 2023-05-10 | |||
| 2021-12-31 | $3.50M 10-K · filed 2024-02-29 | |||
| 2020-12-31 | $2.80M 10-K · filed 2023-03-08 |